Brief: AstraZeneca Says Datroway Approved In US For 1L Triple-Negative BC

Daiichi Sankyo

26/05/2026 07:17

May 26 (Reuters) - AstraZeneca PLC AZN.L:

ASTRAZENECA PLC  - DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC

ASTRAZENECA - FDA APPROVAL OF DATROWAY FOLLOWS PRIORITY REVIEW BASED ON PHASE III DATA

Source text: ID:nRSZ6558Fa

Further company coverage: AZN.L

 ((Reuters.Briefs@thomsonreuters.com;))